United States · FDA National Drug Code directory
ROMIDEPSIN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70121-2250_a007605f-1e3d-4174-b62c-999ebbe27ed5
- Product NDC
- 70121-2250
- Form
- INJECTION, SOLUTION, CONCENTRATE
- Composition / generic term
- ROMIDEPSIN
- Labeler
- Amneal Pharmaceuticals LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260602
- Source listing expiry
- 20271231
Source-listed ingredients
- ROMIDEPSIN — 5 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (70121-2250-1) / 5.5 mL in 1 VIAL · 70121-2250-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →